RRV

(redirected from Rhesus Rotavirus)
AcronymDefinition
RRVRussian River Valley (winemaking region; California)
RRVRecord Relocation Vector
RRVRoot Rule Variable
RRVRapid Reaction Vehicle
RRVRoss River Virus
RRVRidge Racer V (gaming; also seen as Ridge Racer V)
RRVRapid Response Vehicle
RRVRhesus Rotavirus
RRVResident Return Visa (Australia)
RRVRoad Rail Vehicle (Back-hoe excavator used on both rail and normal ground)
RRVRadial Resistivity Variation
RRVReturning Resident's Visa (New Zealand)
RRVRapid Reaction Valve (GSR Ventiltechnik GmbH; Germany)
RRVRaspberry Ringspot Virus (also seen as RRSV; plant pathogenic virus)
RRVRaices Reino de Valencia (Spanish: Kingdom of Valencia Estate)
RRVRecord Relocation Vector (Lotus Notes)
RRVRoyal Rifle Volunteers (UK military)
RRVRaccoon River Valley (Iowa)
RRVRail Route Voyages (Swiss transportation company)
RRVReset Relief Valve (oil production)
RRVRhodesian Reconnaissance Vest
RRVRouting Requirements Vector
References in periodicals archive ?
On October 22, 1999, the Advisory Committee on Immunization Practices (ACIP) recommended that Rotashield(R) (rhesus rotavirus vaccine-tetravalent [RRV-TVI), the only U.S-licensed rotavirus vaccine, no longer be used in the United States (MMWR, Vol.
A live, tetravalent (serotypes G1, G2, G3, and G4) rhesus rotavirus vaccine (RRV), RotaShield, was licensed in 1998.
Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children.
Effect of rhesus rotavirus vaccine on enteric adenovirus-associated diarrhea in children.
In July 1999, CDC recommended that health-care providers and parents postpone use of the rhesus rotavirus vaccine-tetravalent (RRV-TV) (RotaShield(r) [*], Wyeth Laboratories, Inc., Marietta, Pennsylvania), for infants, at least until November 1999.
A rhesus rotavirus, quadravalent oral vaccine, currently being considered for licensure, may be given concurrently with other routine infant immunizations and has an efficacy rate of 80% against severe disease.
An example would be the rhesus rotavirus (RRV) strain MMU 18006, which is immunogenic when used as a vaccine and is serologically related to one of the four human rotavirus serotypes (Bernstein, Glass, Rodgers, Davidson, & Sack, 1995).